Gujarat Themis Biosyn Ltd
GUJTHEM
Company Profile
Business description
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
Contact
S.V Road
Themis House, 11/12 Udyog Nagar
Goregaon (West)
MumbaiMH400104
INDT: +91 2267607080
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
224
Stocks News & Analysis
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,986.20 | 49.10 | -0.54% |
| CAC 40 | 8,378.96 | 11.63 | 0.14% |
| DAX 40 | 24,919.16 | 292.27 | 1.19% |
| Dow JONES (US) | 52,182.74 | 306.63 | 0.59% |
| FTSE 100 | 10,556.28 | 72.06 | 0.69% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 25,820.14 | 522.53 | 2.07% |
| Nikkei 225 | 70,062.32 | 594.21 | 0.86% |
| NZX 50 Index | 13,621.66 | 76.10 | 0.56% |
| S&P 500 | 7,440.43 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,778.70 | 52.80 | -0.60% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |